KUALA LUMPUR – The Russian Direct Investment Fund (RDIF) and Malaysia’s Duopharma Sdn Bhd pharmaceutical company signed an agreement yesterday to supply Russia’s Sputnik V coronavirus vaccine to Malaysia, the Russian embassy in Kuala Lumpur told the Russian news agency (TASS).
"This agreement is just the first step in establishing full-fledged bilateral cooperation, which does not just include shipments of the Russian vaccine but also creates Malaysia’s own scientific and research base to produce it in the country," Russian ambassador Nail Latypov said.
The signing ceremony took place via video link with participation of Health Minister Datuk Seri Dr Adham Baba.
The RDIF said that the contracted doses of Sputnik V for Malaysia will be produced in India, China and South Korea. – Bernama, January 27, 2021
